Neurogene (NGNE) Cash from Investing Activities (2018 - 2025)

Neurogene's Cash from Investing Activities history spans 6 years, with the latest figure at $29.6 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 128.85% year-over-year to $29.6 million; the TTM value through Dec 2025 reached $14.0 million, up 111.18%, while the annual FY2025 figure was $14.0 million, 111.18% up from the prior year.
  • Cash from Investing Activities reached $29.6 million in Q4 2025 per NGNE's latest filing, up from $22.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $29.9 million in Q1 2024 to a low of -$102.6 million in Q4 2024.
  • Average Cash from Investing Activities over 3 years is -$7.1 million, with a median of -$55500.0 recorded in 2023.
  • The largest YoY upside for Cash from Investing Activities was 103324.14% in 2024 against a maximum downside of 35224.39% in 2024.
  • A 3-year view of Cash from Investing Activities shows it stood at $25.8 million in 2023, then crashed by 497.27% to -$102.6 million in 2024, then skyrocketed by 128.85% to $29.6 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Cash from Investing Activities are $29.6 million (Q4 2025), $22.0 million (Q3 2025), and $7.4 million (Q2 2025).